Latest Cancer stem cell Stories
Researchers at Roswell Park Cancer Institute have received a four-year, $11.9 million NYSTEM grant to advance an innovative immunotherapy approach that uses adult stem cells in the treatment of
This week an accepted-ahead-of-print report published online in the journal Stem Cell Research describes the development of a new technology from the stem cell technology start-up Asymmetrex that
-- 2015/2016 clinical research strategy to be previewed SYDNEY, Jan.
This month a keynote address by Dr. James L. Sherley, Director of Boston’s Adult Stem Cell Technology Center, LLC, is featured on the website of the Omics Group.
SAN ANTONIO, December 11, 2014 /PRNewswire/ -- - The first study in the world combining Reparixin, an oral inhibitor of CXCR1/2, with standard
Shangqin Guo, Ph.D., a scientist at Yale University, is the recipient of the 2014 STEM CELLS’ Young Investigator Award.
Today, a new research report from Boston’s Adult Stem Cell Technology Center, LLC, published online in the Nature Publishing Group journal Cell Death and Disease, describes a new advance in
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.